Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-022-01924-4.pdf
Reference55 articles.
1. Wang M, Naganna N, Sintim HO. Identification of nicotinamide aminonaphthyridine compounds as potent RET kinase inhibitors and antitumor activities against RET rearranged lung adenocarcinoma. Bioorg Chem. 2019;90: 103052. https://doi.org/10.1016/j.bioorg.2019.103052.
2. Mendoza L. Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: update. Oncol Rev. 2018;12(2):352. https://doi.org/10.4081/oncol.2018.352.
3. Ferrara R, Auger N, Auclin E, Besse B. Clinical and translational implications of RET rearrangements in non-small cell lung cancer. J Thorac Oncol. 2018;13(1):27–45. https://doi.org/10.1016/j.jtho.2017.10.021.
4. Subbiah V, Gainor JF, Rahal R, Brubaker JD, Kim JL, Maynard M, Hu W, Cao Q, Sheets MP, Wilson D, Wilson KJ, DiPietro L, Fleming P, Palmer M, Hu MI, Wirth L, Brose MS, Ou SI, Taylor M, Garralda E, Miller S, Wolf B, Lengauer C, Guzi T, Evans EK. Precision targeted therapy with BLU-667 for RET-driven cancers. Cancer Discov. 2018;8(7):836–49. https://doi.org/10.1158/2159-8290.CD-18-0338.
5. Ramesh P, Veerappapillai S. Designing novel compounds for the treatment and management of RET-positive non-small cell lung cancer-fragment based drug design strategy. Molecules. 2022;27(5):1590. https://doi.org/10.3390/molecules27051590.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives;Journal of Drug Targeting;2024-05-06
2. Orally Administered Drugs and Their Complicated Relationship with Our Gastrointestinal Tract;Microorganisms;2024-01-24
3. Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges;Frontiers in Pharmacology;2024-01-09
4. Screening of phytochemicals from Clerodendrum inerme (L.) Gaertn as potential anti-breast cancer compounds targeting EGFR: an in-silico approach;Journal of Biomolecular Structure and Dynamics;2023-12-23
5. ПОШУК НОВИХ ІНГІБІТОРІВ ТИРОЗИНКІНАЗИ СЕРЕД 2-(3-R-1H-1,2,4-ТРИАЗОЛ-5-ІЛ)АНІЛІНІВ ЯК ПОТЕНЦІЙНИХ ПРОТИПУХЛИННИХ АГЕНТІВ З ВИКОРИСТАННЯМ МОЛЕКУЛЯРНОГО ДОКІНГУ;Journal of Chemistry and Technologies;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3